These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 874748)

  • 1. Polymorphism of phenylbutazone: properties and compressional behavior of crystals.
    Ibrahim HG; Pisano F; Bruno A
    J Pharm Sci; 1977 May; 66(5):669-73. PubMed ID: 874748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicochemical characterization of spray-dried phenylbutazone polymorphs.
    Matsuda Y; Kawaguchi S; Kobayashi H; Nishijo J
    J Pharm Sci; 1984 Feb; 73(2):173-9. PubMed ID: 6707878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermal behaviour and dissolution properties of phenylbutazone polymorphs.
    Tuladhar MD; Carless JE; Summers MP
    J Pharm Pharmacol; 1983 Apr; 35(4):208-14. PubMed ID: 6133928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid state characterization of dehydroepiandrosterone.
    Chang LC; Caira MR; Guillory JK
    J Pharm Sci; 1995 Oct; 84(10):1169-79. PubMed ID: 8801330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical characterization of solid iopanoic acid forms.
    Stagner WC; Guillory JK
    J Pharm Sci; 1979 Aug; 68(8):1005-9. PubMed ID: 480153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of polymorphs and solvates of 3-amino-1-(m-trifluoromethylphenyl)-6-methyl-1H-pyridazin-4-one.
    Chauvet A; Masse J; Ribet JP; Bigg D; Autin JM; Maurel JL; Patoiseau JF; Jaud J
    J Pharm Sci; 1992 Aug; 81(8):836-41. PubMed ID: 1357154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastable polymorph of etoposide with higher dissolution rate.
    Shah JC; Chen JR; Chow D
    Drug Dev Ind Pharm; 1999 Jan; 25(1):63-7. PubMed ID: 10028419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, characterization, and evaluation of physicochemical properties of different crystalline forms of ibuprofen.
    Khan GM; Jiabi Z
    Drug Dev Ind Pharm; 1998 May; 24(5):463-71. PubMed ID: 9876609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism of diflunisal: isolation and solid-state characteristics of a new crystal form.
    Martínez-Ohárriz MC; Martín C; Goñi MM; Rodríguez-Espinosa C; Tros de Ilarduya-Apaolaza MC; Sánchez M
    J Pharm Sci; 1994 Feb; 83(2):174-7. PubMed ID: 8169784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of moricizine hydrochloride polymorphs.
    Wu LS; Torosian G; Sigvardson K; Gerard C; Hussain MA
    J Pharm Sci; 1994 Oct; 83(10):1404-6. PubMed ID: 7884659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of polymorphs for an LTD4 antagonist, RG 12525.
    Carlton RA; Difeo TJ; Powner TH; Santos I; Thompson MD
    J Pharm Sci; 1996 May; 85(5):461-7. PubMed ID: 8742935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical properties and X-ray structural studies of the trigonal polymorph of carbamazepine.
    Lowes MM; Caira MR; Lötter AP; Van der Watt JG
    J Pharm Sci; 1987 Sep; 76(9):744-52. PubMed ID: 11002813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solubility and crystal nucleation in organic solvents of two polymorphs of curcumin.
    Liu J; Svärd M; Hippen P; Rasmuson ÅC
    J Pharm Sci; 2015 Jul; 104(7):2183-9. PubMed ID: 25950658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorph screening of an active material.
    Láng P; Kiss V; Ambrus R; Farkas G; Szabó-Révész P; Aigner Z; Várkonyi E
    J Pharm Biomed Anal; 2013 Oct; 84():177-83. PubMed ID: 23845379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermodynamic relationships between nateglinide polymorphs.
    Bruni G; Berbenni V; Milanese C; Girella A; Cardini A; Viganò E; Lanfranconi S; Marini A
    J Pharm Biomed Anal; 2009 Dec; 50(5):764-70. PubMed ID: 19570642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical properties of amorphous clarithromycin obtained by grinding and spray drying.
    Yonemochi E; Kitahara S; Maeda S; Yamamura S; Oguchi T; Yamamoto K
    Eur J Pharm Sci; 1999 Mar; 7(4):331-8. PubMed ID: 9971917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The polymorph landscape of dabigatran etexilate mesylate: Taking the challenge to bring a metastable polymorph to market.
    Sieger P; Werthmann U; Saouane S
    Eur J Pharm Sci; 2023 Jul; 186():106447. PubMed ID: 37044200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical characterization of the methanol solvate of urapidil.
    Botha SA; Caira MR; Guillory JK; Lötter AP
    J Pharm Sci; 1989 Jan; 78(1):28-34. PubMed ID: 2709315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physico-chemical characterisation of the modifications I and II of (R,S) propranolol hydrochloride: solubility and dissolution studies.
    Bartolomei M; Bertocchi P; Ramusino MC; Santucci N; Valvo L
    J Pharm Biomed Anal; 1999 Nov; 21(2):299-309. PubMed ID: 10703984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of two polymorphs of salmeterol xinafoate crystallized from supercritical fluids.
    Tong HH; Shekunov BY; York P; Chow AH
    Pharm Res; 2001 Jun; 18(6):852-8. PubMed ID: 11474791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.